KalGene is a biotechnology company developing precision medicine therapeutics designed to slow the progression of Alzheimer’s disease with an antibody-based approach. For more information visit: www.kalgene.com.
Location: Canada, Ontario, Kingston
Employees: 51-200
Founded date: 2007
Investors 3
Mentions in press and media 1
| Date | Title | Description | Source |
| 27.11.2017 | KalGene Pharmaceuticals Closes Series A Financing | KalGene Pharmaceuticals, Inc., a Montreal and Toronto, Canada-based pre-clinical stage company, clos... | finsmes.co... |